Virus-induced respiratory infections can become life-threatening. A team at the Paul-Ehrlich-Institut, together with researchers in Heidelberg, has discovered that flu virus infection limited to the lungs also leads to the ...
Oct 18, 2022
0
46
Abnormal crosstalk between blood platelets and cells lining blood vessels is one cause of deadly organ damage in patients with severe COVID-19, a new study finds.
Sep 8, 2021
0
249
Necrotizing enterocolitis (NEC), a rare inflammatory bowel disease, primarily affects premature infants and is a leading cause of death in the smallest and sickest of these patients. The exact cause remains unclear, and there ...
May 6, 2020
0
71
Even as surgeons have become more highly skilled at performing lifesaving heart surgeries, the overall outcome of the procedure continues to be threatened by complications such as acute kidney or lung injury and neuro-cognitive ...
Mar 18, 2020
0
83
Researchers at the University of Sydney have used biomechanical engineering techniques to unlock the mystery surrounding the mechanical forces that influence blood clotting.
Apr 2, 2019
0
611
Next to other complications, cirrhosis is also linked to abnormalities in hemostasis. However, the role of alterations in platelet function had previously been insufficiently investigated.
Feb 7, 2024
0
0
Researchers led by Professor Steve Watson and Dr. Eleyna Martin from the Institute of Cardiovascular Sciences at the University of Birmingham have delivered a breakthrough for thrombosis researchers, by producing the first ...
Oct 12, 2023
0
12
Researchers from the University of Birmingham, UK, who identified a novel mechanism for platelet activation in pathogenic blood clotting (thrombosis) are now turning their attention to sepsis.
Dec 12, 2022
0
10
Treatments for pulmonary arterial hypertension (PAH)—a type of high blood pressure that affects arteries in the lungs and in the heart—have improved significantly over the past 15 to 20 years and researchers at the University ...
Oct 17, 2022
0
15
Findings from a new study at the Marshall University Joan C. Edwards School of Medicine show that a thymidine phosphorylase (TYMP) inhibitor could help slow thrombosis in COVID-19 patients.
Aug 16, 2022
0
17
